Publicaciones en las que colabora con A. M. Herrero (32)

2014

  1. Canakinumab for gout: A specific, patient-profiled indication

    Expert Review of Clinical Immunology, Vol. 10, Núm. 3, pp. 339-347

  2. Clinical manifestations and diagnosis of gout

    Rheumatic Disease Clinics of North America, Vol. 40, Núm. 2, pp. 193-206

  3. Crystal arthritis: Environment and genetics in gout: A maze for clinicians?

    Nature Reviews Rheumatology

  4. Disease overview

    Managing Gout in Primary Care (Springer Healthcare), pp. 1-12

  5. Managing gout in primary care

    Springer Healthcare, pp. 1-69

  6. Reply: Gout treatment-more tablets might be needed

    Nature Reviews Rheumatology

  7. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 177-182

2012

  1. Erratum: Evaluation and treatment of gout as a chronic disease (Advances in Therapy (2012) 29:11 (935-46)

    Advances in Therapy

  2. Evaluation and treatment of gout as a chronic disease

    Advances in Therapy, Vol. 29, Núm. 11, pp. 935-946

  3. Uricosuric therapy of hyperuricemia in gout

    Gout and Other Crystal Arthropathies (Elsevier Inc.), pp. 148-153

2011

  1. A two-stage approach to the treatment of hyperuricemia in gout: The "dirty Dish" hypothesis

    Arthritis and Rheumatism, Vol. 63, Núm. 12, pp. 4002-4006

  2. Uricosuric therapy of hyperuricemia in gout

    Gout and Other Crystal Arthropathies: Expert Consult: Online and Print (Elsevier), pp. 148-153

2009

  1. Artritis microcristalinas

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 33, pp. 2205-2210

  2. Influencia de la historia natural de la enfermedad en el diagnóstico previo en pacientes con gota

    Reumatologia Clinica, Vol. 5, Núm. 6, pp. 248-251

  3. Microcrystal deposition in osteoarthritis

    Medicine, Vol. 10, Núm. 33, pp. 2205-2210